Google TrendLAMINE YAMAL (5000+) — "You want to play for Morocco?": Getafe defender provokes Yamal with shocking words
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "The safety and oncologic" (30 stories)

Top Headline Story

Performance and safety of a multi-cancer early detection test: the PATHFINDER 2 study
Lead StoryNaturegeneral
Sep 22

Performance and safety of a multi-cancer early detection test: the PATHFINDER 2 study

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE94WFFfUDBmXy10ZGp5ajYyOGYyMVF0OFhrb1ZWVDFESXNoLVZMUzh3X1FxNTdRQ1hSX3YzXzlVSV9lYldJMnZrNnQ1VGo2UDBGZjY1RTlyWGFpcTBXNEZZ?oc=5" target="_blank">Performance and safety of a multi-cancer early detection test: the PATHFINDER 2 study</a>  <font color="#6f6f6f">Nature</font>

Real-time search volume
5000+24m ago

lamine yamal

"You want to play for Morocco?": Getafe defender provokes Yamal with shocking words

500+24m ago

thélyson orélien

Acclaimed Author Denies Using A.I. but Admits Plagiarism

500+34m ago

abdulrahman alfozan

OpenAI engineer arrested in bugging of executive conference room

500+34m ago

pope francis

The Myth of St. Francis

Search Results for "The safety and oncologic"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
AI Joins the Safety Team: Language Models Tackle Root Cause Analysis in Radiation Oncology
Bioengineer.orgtech

AI Joins the Safety Team: Language Models Tackle Root Cause Analysis in Radiation Oncology

<a href="https://news.google.com/rss/articles/CBMitAFBVV95cUxOX29MSDhhcW9rdlpYOWRIT1RNbmREVDRGZm5iczRNY2pDcE9nNnJFRTNTdi1vV3c4bHROUkpBR3gta09oUDI4RXVaV0ExeThFaEd5REttZ0UzZ2p2dXVQWlJ2bldrWHNaakNRNzYwRVpsMmpxOGk1azdoeVJzMmJMRk9TZDdaZF9oRkJELXZMODduNHhvX2F4V1VYdVl2dWJPbF9VZkdYTnhQekVkTE9EVm5hako?oc=5" target="_blank">AI Joins the Safety Team: Language Models Tackle Root Cause Analysis in Radiation Oncology</a>  <font color="#6f6f6f">Bioengineer.org</font>

76 Real-World Safety of Trastuzumab Deruxtecan in HER2-Low Metastatic Breast Cancer: Insights From US Community Oncology Practices
CancerNetworkworld

76 Real-World Safety of Trastuzumab Deruxtecan in HER2-Low Metastatic Breast Cancer: Insights From US Community Oncology Practices

<a href="https://news.google.com/rss/articles/CBMi6AFBVV95cUxONm92SGF2U0dzOGJDY2xLNXRiTVEwSkVmTXJJNlJWYm94QWwwLVd5ZHl4NDBINGNOd1doMElzdXNXSlFkWk1BbEtxWTVWMm9KS0JGTWcyU2J6QmtwUjRCS3d1RjNUMEVkNmdBU0tqQk9WSjhuanVMb01oMHBsRktvWGxveUhBcGw2VDdneUExRlE1MUFFVjM2LXRjbkIzRnZkenhBTWlsU3hOYmRVT2R2cTZDYkpLZHFnZUpCeTgtSUNUMFRxUVd4cjExa3NtZ2pEclhFb2F5Mi1vcjB2Y2VNOU95NklCN09Z?oc=5" target="_blank">76 Real-World Safety of Trastuzumab Deruxtecan in HER2-Low Metastatic Breast Cancer: Insights From US Community Oncology Practices</a>  <font color="#6f6f6f">CancerNetwork</font>

Sun Safety Facts | Skin Cancer
Centers for Disease Control and Prevention | CDC (.gov)world

Sun Safety Facts | Skin Cancer

<a href="https://news.google.com/rss/articles/CBMiY0FVX3lxTE9OUU9SZ2dfeV9DRF9aS1N6Ym9BY0w2ajJFWHV5UlBFUkE2VU4xR0FGT0VXbzF1b3lJM2g4R1FGRURXMS1MOUlSanZuXzE0QUdPdFFHd0VKbm4wZ21kWVlXZm9XVQ?oc=5" target="_blank">Sun Safety Facts | Skin Cancer</a>  <font color="#6f6f6f">Centers for Disease Control and Prevention | CDC (.gov)</font>

Percutaneous Cryoablation Versus Microwave Ablation for Hepatocellular Carcinoma: Comparative Study of Safety and Oncologic Outcomes
RSNA Journalsgeneral

Percutaneous Cryoablation Versus Microwave Ablation for Hepatocellular Carcinoma: Comparative Study of Safety and Oncologic Outcomes

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE90V2d2S3NaRV9DOFE5YkRlLWZWXzFEQ3p4eUFfbDNMS3NxZmI4WkprMHVEdlRrSGRVUFRnQ0g3ZGhXdTNlck5lMzVtbEdNRk9aRUxMUmJOeWpQQUU3R2JV?oc=5" target="_blank">Percutaneous Cryoablation Versus Microwave Ablation for Hepatocellular Carcinoma: Comparative Study of Safety and Oncologic Outcomes</a>  <font color="#6f6f6f">RSNA Journals</font>

Protecting the Frontline: The Evolution of Hazardous Drug Safety in Oncology Nursing
Oncology Nursing Newsgeneral

Protecting the Frontline: The Evolution of Hazardous Drug Safety in Oncology Nursing

<a href="https://news.google.com/rss/articles/CBMiuwFBVV95cUxQc1RfeUZLQzRmOXB0X29mX2FseGxmc3ctZGdGRUNuVjRKVXgtUDVWeTZxS08wS1d1RmR1MDlJVzB1dm5KSFpmcURKMWVfWmEzQ3djX0steHZhNEJSc3ZXeHVRV1ZTQjZ3SW1XcG1YdU5zWW55UXFJWWowOUVkZGxaZ21KN0ZwWmlUbTV0SGhfOVFlSEhwaGcxeEZ4SzUwT0s0NUozcHJoeUV5OEZ6Ykk2RG1vX3daLWkwenln?oc=5" target="_blank">Protecting the Frontline: The Evolution of Hazardous Drug Safety in Oncology Nursing</a>  <font color="#6f6f6f">Oncology Nursing News</font>

Peptide Safety and Cancer Risk: What You Need to Know
Dana-Farber Cancer Institutegeneral

Peptide Safety and Cancer Risk: What You Need to Know

<a href="https://news.google.com/rss/articles/CBMinwFBVV95cUxON3kzQ1hOTXZCQTU5NkUtdkxCU2xWNE9rbUN4NkZmTDBnNVZtaUMzdXZsb2FNS0FmUG03eVBLcHhSSlRpb1pSWEdraElXUWtzTWdSbllIX1BJdmxKRzU3U0g1OHJxMm53ZkxJU09QbTRTelp1dS11VERtTlhkR09kdUN2RVVfcWJVbVB5U3hja0VGQ2htTWJXWHc2S2ItVmc?oc=5" target="_blank">Peptide Safety and Cancer Risk: What You Need to Know</a>  <font color="#6f6f6f">Dana-Farber Cancer Institute</font>

Zele in Combination With Pembrolizumab Shows Promise in Bladder Cancer
Oncology News Centralgeneral

Zele in Combination With Pembrolizumab Shows Promise in Bladder Cancer

<a href="https://news.google.com/rss/articles/CBMixgFBVV95cUxOcVo2bzdEdUFxSVBCbHByMEF3dlJsZmdfZlh5WHAwaUJyMkVkZG4wOWFONVBadkFwcDJyNFlaNThXTDQ3eVE5VlJkMFFJcFdSVS1pNFFhRWdWWnhXRkJKZFoxbGlVQThkMzE3bTJRWktzdm81OUIzNDBGTXNQSzJhWGNiNEtNRFdLQWs2RUdQYWVhem9EZzktalhiMi1UdFRSX0I2Nm1MVElyV2tONUxHblJaTTRIb05ZbHhmRlV6ZzdZclZOdHc?oc=5" target="_blank">Zele in Combination With Pembrolizumab Shows Promise in Bladder Cancer</a>  <font color="#6f6f6f">Oncology News Central</font>

Test Substantially Increased Cancer Detection With Robust Performance and Favorable Safety at 2026 ASCO Annual Meeting
GRAILgeneral

Test Substantially Increased Cancer Detection With Robust Performance and Favorable Safety at 2026 ASCO Annual Meeting

<a href="https://news.google.com/rss/articles/CBMixAJBVV95cUxPNFE3a2tkMTJpVjBOdm5YX0VOdTdRQ2NrQ0JxYXZUQ3ZoNzZYaWdiU29sdGZSemNGR1pfQl8zVEplMXAzcl9hUGdoZnJMT1dOWkdmUExIYkVnamJCa3dmRGllY3JCOHNVOFVyTVhGMDR0VFU3czJWb2FFbk12NTkzOG41eHlibURSNVhvUFgzSmNpb2M1dFRORS1ySHdpYnQ3S01SWE53THE3ZjNpWWJVZW1ublRmNmVTaFhLUlVndEV0NHZoMlFYTl9iNTVka08yTUV1U2tuTGk2NnNqUzNla2Y4LXI0UnBOZ1ZSVElZS05NT0MxREx3VlB2d1BXMjdrOFJVczRYVU4zcW5ReGdHQ1l1MWxfelRQVUJYVTdMWUNwUWNiMHg4Q1NDS0V4Sm0wc1MySzc2WFhoODFMYVYydGFHcHc?oc=5" target="_blank">Test Substantially Increased Cancer Detection With Robust Performance and Favorable Safety at 2026 ASCO Annual Meeting</a>  <font color="#6f6f6f">GRAIL</font>

Large Study Reinforces Hormone Therapy's Safety in Young Patients With Cervical Cancer
Physician's Weeklyworld

Large Study Reinforces Hormone Therapy's Safety in Young Patients With Cervical Cancer

<a href="https://news.google.com/rss/articles/CBMiwAFBVV95cUxPT1JnUmgxZUwtNWlQRnRFb0dBazRaOU55ajJYblMtUmZYNlhtclBlaUJBYXg2S1VKZXB5N2ZQMjR5WWFrZU5UUGw2ZW40LTRPY1pQQjV4VUZSWDRiSGZmeWNPOG1EcDhGdGlyWG5zX0ZlY3Y1UHplTnNodTE5WkhieEdzWXFQbTFQU3RZY3p3dFpHQmZfSXlGbmx3QXY3aTNMV1I5aFFPTDlJQ0V4em9MNkdzRURlaTZZbTdIUXZwdlM?oc=5" target="_blank">Large Study Reinforces Hormone Therapy's Safety in Young Patients With Cervical Cancer</a>  <font color="#6f6f6f">Physician's Weekly</font>

Namodenoson Demonstrates Favorable Safety in Advanced PDAC
Targeted Oncologygeneral

Namodenoson Demonstrates Favorable Safety in Advanced PDAC

<a href="https://news.google.com/rss/articles/CBMilgFBVV95cUxNOWF3bDNUbnRXRnZMSUpuMDJDY240d1VWbmQ4RFEyeS00QXhOUG5MbTVzOVJUbXlnYkY1VTBhX2dubUprMFZZT3dJS2Nsa1JIdk9TTW10WmVOeUpFN0x5cWZpdG1KTHJCSEJfVnhxUmExNkJRam5BNnJtcmg4YXdVVVBKYndUQndmbjhWZUlVUFJOQkZ0aGc?oc=5" target="_blank">Namodenoson Demonstrates Favorable Safety in Advanced PDAC</a>  <font color="#6f6f6f">Targeted Oncology</font>

Natural supplements in breast cancer therapy: translational evidence, clinical safety, and emerging challenges
Frontiersgeneral

Natural supplements in breast cancer therapy: translational evidence, clinical safety, and emerging challenges

<a href="https://news.google.com/rss/articles/CBMijgFBVV95cUxOS0RGQVY3aWUydzdOZFhpZjRPWXcxcG1KdTcxNEdHRUlHczR1aHNBdjA4UkR3SlpsNlZKU000SUlCYS1YY0M3Qk9JVlZCbFNYSm9sYUZYNllDdDZRV294clZxTkpLZGlPYUVObGlmX1FUbHd4cjR4d0owRUV2b0lEYThXLVRCdUM2Mm92Vjln?oc=5" target="_blank">Natural supplements in breast cancer therapy: translational evidence, clinical safety, and emerging challenges</a>  <font color="#6f6f6f">Frontiers</font>

A Multicenter Single-Arm Phase II Trial Evaluating the Safety and Efficacy of Panitumumab and Irinotecan in Patients with NeoRAS Wild-Type Metastatic Colorectal Cancer (C-PROWESS Trial)
EMJgeneral

A Multicenter Single-Arm Phase II Trial Evaluating the Safety and Efficacy of Panitumumab and Irinotecan in Patients with NeoRAS Wild-Type Metastatic Colorectal Cancer (C-PROWESS Trial)

<a href="https://news.google.com/rss/articles/CBMi1wJBVV95cUxOVF9hQnFYbUJtQkJrcWo5V293SVNSVGs0Z2FPbjBtdTBiRGkyYjMxcTFFdk1MYmFCNWVORkV4MEFVTFRoZTl1aDk0SGZPV1A5WmI5MjU3eWswTzRtM3BNME5XYkk4YlY5T3VuLUcySmZ1andybzgxUUJ1aEQ2S09rdm15R2wzaURYTXFfeWZ4dFZ0cUI0TzJlU1VLekstamh6RFQxZHdDRFRLNVI0aV95b1RPRnNQQjQxTnlneE9OMk1BM3BGSERKOXBJYWJFUzZ2MkRzN09MT3RVdDZRb3VnSkIycWRpTTNtd0Y2SFBPX01PQVhNLU9YRmZZc0NFMzUwQ0g2SHNFWWZNVWNMN1QxNVozQV8wUEU0bFFvLV90MEdVQ0VrVWtKc2tmXy14SloxUUdRQjN1V2Fib1BSWlRZMGpnRExZSzR0aGRYNE4tbjdNcS1ZM0JN?oc=5" target="_blank">A Multicenter Single-Arm Phase II Trial Evaluating the Safety and Efficacy of Panitumumab and Irinotecan in Patients with NeoRAS Wild-Type Metastatic Colorectal Cancer (C-PROWESS Trial)</a>  <font color="#6f6f6f">EMJ</font>

Organ Preservation in Female Radical Cystectomy: Balancing Oncologic Safety and Quality of Life
ASCO Daily Newsgeneral

Organ Preservation in Female Radical Cystectomy: Balancing Oncologic Safety and Quality of Life

<a href="https://news.google.com/rss/articles/CBMiuAFBVV95cUxQSTg1RGoxVVVKVFpqRzNQZ0ljY2RNVFlIVzRBOUVjR3k0enFVREpHYmlwM2hOMllWRmVNX19LS2RqdEhIb2JLOXpRRzd6Q1lobkZGaXF6TXlGOTJBeHJwOGtfTldnLUpMZmJBUXpJQkhmUHU2aUdWRDNuenpEbk9EOS1FTWM5aG1NYjEtbk9oelBETkxJZlliNVFndmw5Z0tOa2IyQVU0UGVGeHFuemtZWFZRV0x1Rm50?oc=5" target="_blank">Organ Preservation in Female Radical Cystectomy: Balancing Oncologic Safety and Quality of Life</a>  <font color="#6f6f6f">ASCO Daily News</font>

Dolly's Cancer Death; Mammogram Safety Alert; Chemo Drug Shortage Worsens
MedPage Todaygeneral

Dolly's Cancer Death; Mammogram Safety Alert; Chemo Drug Shortage Worsens

<a href="https://news.google.com/rss/articles/CBMidkFVX3lxTE5lbUNxUkRBU3pZVVZoRFJwU1dMdVRoMmRiUWs1YVVFbDdSNF9MZW9heWRsZ1Eyd1M3anVDZFpfSE1uN0RuaU5qNWJYZEtWcWVITkktd3JhcnFObFFGTmVjYndGZVRoQ0k0LUV4NHVieUFxNExGaWc?oc=5" target="_blank">Dolly's Cancer Death; Mammogram Safety Alert; Chemo Drug Shortage Worsens</a>  <font color="#6f6f6f">MedPage Today</font>

Comprehensive study settles debate over diet safety for patients with cancer - UF Health
University of Florida Healthscience

Comprehensive study settles debate over diet safety for patients with cancer - UF Health

<a href="https://news.google.com/rss/articles/CBMiqwFBVV95cUxPOFpYVkk2MUkyblBySllkaWV2WlA5bndDMElzN3N1ZDlCa1RxVnRZZVVfclhRT21DZDA5ZVk4dGVNcGxFdHFBdDItWW9udDR4cUVkdmpEZk9OTW0ycndNSmxQRFV5bUFJY3h3NUIyTXJUV18wY2lZckNXS2Q5M2I5bDJINTI0bzVfZjhKRlZiQjN0RnV0YmtvU3FMSkdhNTFsRElxeWZzbHBkSjQ?oc=5" target="_blank">Comprehensive study settles debate over diet safety for patients with cancer</a>  <font color="#6f6f6f">UF Health - University of Florida Health</font>

Cancer Drug Tazemetostat (Tazverik) Pulled Due to Safety Concerns
Oncology News Centralgeneral

Cancer Drug Tazemetostat (Tazverik) Pulled Due to Safety Concerns

<a href="https://news.google.com/rss/articles/CBMimgFBVV95cUxQdmt0a0ctcDA3T2hfbTZoc0ZtQmlXOTVqQUNzbW9fcnk3WUVwMHJVcVhYNFBHeHdZZndOOG5VSDVObnJvMU1QZlR5U09KN096RWxxVGZIYk1pcm9FVjZkOHhBZW1mcTVTcTNfelpOaElCNTFFanItb25ZbFZxcS1ia0lFeTNhb1NVZlhFdDlwUldhLXdUMWM5aXRR?oc=5" target="_blank">Cancer Drug Tazemetostat (Tazverik) Pulled Due to Safety Concerns</a>  <font color="#6f6f6f">Oncology News Central</font>

Varsetatug Masetecan Exhibits Early Efficacy, Safety in Late-Line Colorectal Cancer
Targeted Oncologygeneral

Varsetatug Masetecan Exhibits Early Efficacy, Safety in Late-Line Colorectal Cancer

<a href="https://news.google.com/rss/articles/CBMitgFBVV95cUxQNFpzTDg1UWJTbF9TWkhIbVZIak9tbFlZWllVVVo2NVJxLW9CeVpRbC12MHdUNmJscUVyYVZQdzlQLU4zS3ZEM2J5X0lGSDdFb3RZd2REVWZoOVhDdnh1R1Y5VWpvUFMxV3oxT1ktdDBjMnJwQ3NyZVM2eHhPalVGQlNUN05hNllzLVI0dXRmT2tTdHUwSk00VzVwWWpfb2Y2NU83WExfRXpjWFlUMWpTMk14ZkFfQQ?oc=5" target="_blank">Varsetatug Masetecan Exhibits Early Efficacy, Safety in Late-Line Colorectal Cancer</a>  <font color="#6f6f6f">Targeted Oncology</font>

Actinium-225 Demonstrates Safety and Responses in mCRPC
Targeted Oncologygeneral

Actinium-225 Demonstrates Safety and Responses in mCRPC

<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxQaGgtVXdoZWgzRkJOeGtNSFUxbXdYbU01cnphLVBwdmtRZnZQOVlSRUNvNVY0OVpRNWc3Q3dfSndEU1RqdnNfV0J0VllFcnB0TjlLZ1RLU1hlQy1zbkZtNHcwUXBEbTdwZFc0dUZYVGotUjRUdG9CaWxzbmxGV1lYaUFCcVh5OVRLUTF1U1Q1ZDNVUQ?oc=5" target="_blank">Actinium-225 Demonstrates Safety and Responses in mCRPC</a>  <font color="#6f6f6f">Targeted Oncology</font>

Fruquintinib/Sintilimab Yields Efficacy, Safety in Advanced pMMR Endometrial Cancer
Targeted Oncologygeneral

Fruquintinib/Sintilimab Yields Efficacy, Safety in Advanced pMMR Endometrial Cancer

<a href="https://news.google.com/rss/articles/CBMitgFBVV95cUxPeXVEMGl2bUdsaHh2UG9Kc09nVVV6Uk1lMnZ1b09YdTlJUDJaQk1UUFBqOGhCbkZ2WVpWdU81WGFSUXFBdGw5TUZKcVUwZklDN29ROGtFNEdMN3VGdVUtdk5rMXYtbmhDTjBCVnJISnRQMEpRSXNocnExRVVyZDY0WHRJby1Ea2NlWmpGbEhsbTJFMGRNZXlaUHVzMm5Za3h3M1VYdkItWFJMekZLSWUwNThOZ2pPdw?oc=5" target="_blank">Fruquintinib/Sintilimab Yields Efficacy, Safety in Advanced pMMR Endometrial Cancer</a>  <font color="#6f6f6f">Targeted Oncology</font>

Recent FDA Cancer Drug Safety Warnings and Updates
Oncology News Centralgeneral

Recent FDA Cancer Drug Safety Warnings and Updates

<a href="https://news.google.com/rss/articles/CBMingFBVV95cUxNdXc3eGlKcWllbWRqNzZhSnJCdzZ4b3p6RnVTdlRYUmx4ZlZOQmk1RWNMemUyMVQ3cG9GWVJLMXFWTkZlUDVqNk1Uc3NtQV9Wbm9Pbk1FWjJya3N1V3NqVzBYM0lsdmJpVWhoNFgwM082dzFCVkg2OVR3QXEwYlhSLWJuVjg4aEhoZ3A4UDB0RWpXZ1ZMclZ1aE1KZ0NYQQ?oc=5" target="_blank">Recent FDA Cancer Drug Safety Warnings and Updates</a>  <font color="#6f6f6f">Oncology News Central</font>

Ipsen backs away from cancer med Tazverik after safety signals emerge in lymphoma trial
Fierce Pharmageneral

Ipsen backs away from cancer med Tazverik after safety signals emerge in lymphoma trial

<a href="https://news.google.com/rss/articles/CBMitgFBVV95cUxPbmpmRnozTkdRMWJHakhKYV9pVHh0WXpzNUtGOE1SRGpyRlFrOXZBTFJfSEF5Y0tmN256UGdJdVBVYmxzNlNqMENrQ3NDMVFteGZWWGdTbE02ZTBvLUl0RC1LMmotWmpaSjZNWkU4MjcxVkJQYnIyb2VuTE1wRFFUQ1NEMW93Z3FKQTlzMEdpdWNJTTB0NGRlWGlUX2FCQ0RVa3JUYmNKS0NEMFZEaWtqVEdDemF6Zw?oc=5" target="_blank">Ipsen backs away from cancer med Tazverik after safety signals emerge in lymphoma trial</a>  <font color="#6f6f6f">Fierce Pharma</font>

Linking Mechanism of Action to Safety Profiles in mCRC Treatment
Oncology Nursing Newsgeneral

Linking Mechanism of Action to Safety Profiles in mCRC Treatment

<a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxNZ2poQi1ERFJmMENrUzRfTXNrS3ZNNmI0d2ZuS2x1THZjVFBzXzNSTHk4cUpKZ1NsclBCSmNITEs2dDQzLWYweC10UGpDc291X3QwQndsbTg5cjZXcWNDWERKcWJ6bVlXLTE0YlNKWVAtcmxGZ2ZMSFQ3NXRfY1pENDNJR1dpbkZ0NGJWbWppcnFsUDZGdW5rdmRTV3J4alJrWlE?oc=5" target="_blank">Linking Mechanism of Action to Safety Profiles in mCRC Treatment</a>  <font color="#6f6f6f">Oncology Nursing News</font>

How Do Pharmacists Protect the Safety and Effectiveness of Immunotherapy?
Oncodailyworld

How Do Pharmacists Protect the Safety and Effectiveness of Immunotherapy?

<a href="https://news.google.com/rss/articles/CBMigAFBVV95cUxPWjBaVHY1bjdGSjFLSUZYQTg5Y1ViNU1vVTg3RWJXWWlQYU9OeTg5TGlFQUVPa2lWOXdJTGpBa2FFb2tnSDNuOUEwOEVTQUtKMllmY3FWREVlQWdLb3lXbWVyU1NXVHZybFdKUWM0VTBLUXBqTTR3X2xqek5lWHlsWQ?oc=5" target="_blank">How Do Pharmacists Protect the Safety and Effectiveness of Immunotherapy?</a>  <font color="#6f6f6f">Oncodaily</font>

Testosterone replacement therapy following definitive treatment for prostate cancer: a scoping review of safety and efficacy | International Journal of Impotence Research
Naturegeneral

Testosterone replacement therapy following definitive treatment for prostate cancer: a scoping review of safety and efficacy | International Journal of Impotence Research

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9IaEhzaGs4TGJoMTh0ckVlYS1DMVVIMFBqN0NXQkU4TWxqSlNwcnlBNkpqVV9tY2FCMktyODl1NF9vZm90bWgzQ3E0U0pFSFdCaUt0S2F3NGhiQlNmNWw0?oc=5" target="_blank">Testosterone replacement therapy following definitive treatment for prostate cancer: a scoping review of safety and efficacy | International Journal of Impotence Research</a>  <font color="#6f6f6f">Nature</font>

Wellness in Oncology Nursing Tied to Safety and Outcomes
Oncology Nursing Newsgeneral

Wellness in Oncology Nursing Tied to Safety and Outcomes

<a href="https://news.google.com/rss/articles/CBMilwFBVV95cUxQMzV3ZXI2UWZBTVpzSE5QX0JkcHJ6QmNKOXd5ZjFNNUJRSUlTaDY1TUVoMXlWNFc5YXFyV3czQ3pybnhQUXNVQTFBM2hpU284MUh4SkEyaHMxVnM0X0FOeU9Fa210dUxaOWtlS1dGMWtyaUh6LXlOZGpvdzBKWXk3QjdzczQwS2NRQTFSTTNFRXlsTUdmMXhN?oc=5" target="_blank">Wellness in Oncology Nursing Tied to Safety and Outcomes</a>  <font color="#6f6f6f">Oncology Nursing News</font>

Dr Pant on Managing the Safety Profile of Daraxonrasib in Pancreatic Cancer
Targeted Oncologygeneral

Dr Pant on Managing the Safety Profile of Daraxonrasib in Pancreatic Cancer

<a href="https://news.google.com/rss/articles/CBMirAFBVV95cUxPWUhBNXV1bVd5R05aVzNJVV9OSkQxX2RhbWtYYm45dEJwREFtQVdfTERYYWpNZXF6M3pXZjBCUUV0blJwT0t3UVVLQ1hUc095Xy1wQk1pNElqWnhkcWNFX3BBSDl5T19YdEJoTDBWT2hYYXpxanM1SDlVWDRJTlVmWVNKaHBvUTJGRl9EWnpfN0szTl9hLWhUVFNqSzZmdEtodjJXYmZoUlZuSnpv?oc=5" target="_blank">Dr Pant on Managing the Safety Profile of Daraxonrasib in Pancreatic Cancer</a>  <font color="#6f6f6f">Targeted Oncology</font>

Linvoseltamab Plus Carfilzomib Shows Manageable Safety in RRMM
Targeted Oncologygeneral

Linvoseltamab Plus Carfilzomib Shows Manageable Safety in RRMM

<a href="https://news.google.com/rss/articles/CBMimwFBVV95cUxQZkdvNi13TllkN3FQclZRQlVkRTNvUlFvcDN0a0Z5aFB3TjFMbUFEN3dWUlZLa21LSUJaLXpPczFDS2VOcU1jU3NXRWNjaWFXcGRUNXByTl9XbVVpNmVCZGQtYlhld3RXV0JJVmwxLWMwNzg4ajlUYTkzS0VkS3VkZUdXVlZEbkcyZ1ZNTDlhOXNOUHBzVkVRdHowUQ?oc=5" target="_blank">Linvoseltamab Plus Carfilzomib Shows Manageable Safety in RRMM</a>  <font color="#6f6f6f">Targeted Oncology</font>

Phase 1 clinical trials, explained: 11 things to know
UT MD Andersontech

Phase 1 clinical trials, explained: 11 things to know

<a href="https://news.google.com/rss/articles/CBMihwFBVV95cUxQVVlxQ256ZWRvU003b01rVnZxWHFvR09WSXY2QVpxNmZVSnlRdHFxNENKUk5IcmlxVW1NaUNMX0FndEZyemRRb1NoRlRKdjFraHhqcko4WEI4RFE5Y09jX01YMEJpWWtJcktVTHNyUTRCSjdZWTVfQS1OLVVHMHQ4T0VQNGtpNzA?oc=5" target="_blank">Phase 1 clinical trials, explained: 11 things to know</a>  <font color="#6f6f6f">UT MD Anderson</font>

Overview of the Safety Profile of CAR-T Therapy
Oncology Nursing Newsgeneral

Overview of the Safety Profile of CAR-T Therapy

<a href="https://news.google.com/rss/articles/CBMiiwFBVV95cUxOMmRIeThzOFdseDBwTFJnOFhEVTBEMEhDX1RYVWY2Uk5LTm80MDYtRmduTDBZT1dQQWVVbG1MWGV1VXNadWxaeTczSHBUNGlaam0wVTlWZllXNC1qTTR5Y2xxOEtwc0UwZzZxOWFzMWlacDEtbnVrUE0zdWZObHVPQ1BweWRNank5czdN?oc=5" target="_blank">Overview of the Safety Profile of CAR-T Therapy</a>  <font color="#6f6f6f">Oncology Nursing News</font>

"The safety and oncologic" — Live Google News Trends & Headlines